Semaglutide 30mg

Description

Semaglutide 30mg research peptide

Semaglutide is a modified GLP-1 analog used in laboratory investigation of incretin-receptor pharmacology and metabolic-signaling models. PubChem records the molecular formula as C187H291N45O59 and molecular weight as approximately 4114 g/mol. This 30mg format supports larger controlled analytical and non-clinical research workflows.

Research applications

• GLP-1 receptor binding and activation assays
• Incretin-pathway and metabolic-signaling research models
• Peptide identity, purity, stability, and analytical method development

Product specifications

• Label amount: 30mg
• Molecular formula: C187H291N45O59
• Molecular weight: approximately 4114 g/mol
• Documentation: review the lot-specific COA when available

Research use only. Not intended for human or animal use, consumption, administration, diagnosis, treatment, weight management, or any medical application.

Experimental design and evidence boundaries

Published observations involving this material may depend on model system, concentration, exposure interval, assay platform, controls, and material provenance. Results from biochemical, cellular, ex-vivo, or animal models should not be represented as evidence of human safety or clinical effectiveness. Researchers should document lot identity, solvent system, assay conditions, reference standards, and acceptance criteria before comparing results across studies.

Identity, purity, and traceability

Identity and purity should be evaluated against the lot-specific certificate of analysis and any available chromatographic or mass-spectrometric documentation. The product label and current COA control over general website information when specifications differ by lot.